Notice of Results
One Health Group plc
("One Health", the "Company" or the "Group")
Notice of Results
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', will announce its preliminary results for the year ended 31 March 2026 on Monday, 6 July 2026.
Online investor presentation
Adam Binns, Chief Executive Officer, and Derek Bickerstaff, Chairman, will provide an overview of the Company's preliminary results via the Investor Meet Company platform at 12:00pm BST on Monday, 6 July 2026. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet One Heath Group plc via: https://www.investormeetcompany.com/one-health-group-plc/register
Investors who already follow One Health Group plc on the Investor Meet Company platform will automatically be invited.
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
For more information, please contact:
One Health Group plc
Derek Bickerstaff, Chairman
Adam Binns, CEO
Via Walbrook PR
Panmure Liberum (Nominated Adviser and Broker)
Emma Earl, Will Goode, Mark Rogers
Rupert Dearden
Tel: +44 (0)20 3100 2000
Walbrook PR (Media & Investor Relations)
Alice Woodings / Paul McManus /
Rachel Broad
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com
Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
+44 (0)7747 515 393
About One Health Group plc (www.onehealth.co.uk)
One Health engages 88 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2026 provided much needed care to 18,931 new patients, through over 50,000 consultations and over 8,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 140 professionals across 14 independent hospitals and 40 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from 29 ICBs across England as well as contracts with local NHS trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNORDZGMVKKDGVZM
